Switzerland, with its nearly 9 million population, is recognized for its robust medical technology sector, bolstered by strong fundamentals and political stability.
The Mutual Recognition Agreement (MRA) between the European Union and Switzerland has been impacted by the EU's new medical devices (MDR) and IVDs (IVDR) regulations, necessitating compliance with Swissmedic Switzerland medical device registration requirements to legally sell devices under the Medical Devices Ordinance (MDO).

Switzerland's IVD market leads Europe in per capita spending (€88.9 in 2021). It is set to grow from $113.1M (2024) to $132.4M (2030) at a 2.4% CAGR, with reagents making up 68.88% of revenue (2024), reflecting strong investment in diagnostics.
Medical devices placed on the market in Switzerland are regulated by the Swiss Agency for Therapeutic Products (Swissmedic). The primary legislation is the Medical Devices Ordinance (MedDO) and the Ordinance on In Vitro Diagnostic Medical Devices (IvDO), which came into force on 26 May 2021 and 26 May 2022 respectively. Both ordinances are substantially aligned with EU Regulation 2017/745 (EU MDR) and EU Regulation 2017/746 (EU IVDR).
Switzerland is not part of the EU single market for medical devices. However, devices placed on the Swiss market must bear the EU CE mark, obtained through conformity assessment under the EU MDR or EU IVDR. Swiss-based Economic Operators must also obtain a Swiss Single Registration Number (CHRN) and register their devices in swissdamed, Switzerland’s medical device database. Manufacturers established outside Switzerland must appoint a Swiss Authorised Representative (CH-REP).
Switzerland applies the same risk-based classification system as the EU. Medical devices are classified as Class I, Class I sterile, Class I measuring, Class I reusable, Class IIa, Class IIb, and Class III under the MedDO and EU MDR. IVDs are classified as Class A, Class A sterile, Class B, Class C, and Class D under the IvDO and EU IVDR. Classification determines the applicable conformity assessment procedure and whether Notified Body involvement is required.
Switzerland recognizes CE marking; therefore, it accepts CE certificates issued by EU Notified Bodies and EU Declarations of Conformity. However, Swiss-specific obligations, including CH-REP appointment, economic operator registration, swissdamed registration, and vigilance reporting apply in addition to CE marking.
CE Marking under EU MDR (as recognized by MedDO)
CE Marking under EU IVDR (as recognized by IvDO)
Key Swiss registration requirements
Documentation requirements depend on device classification and the applicable conformity assessment procedure under the EU MDR or EU IVDR. In general, manufacturers should prepare:
A Swiss Authorised Representative (CH-REP) is a legal entity established in Switzerland that acts on behalf of a manufacturer located outside Switzerland. The CH-REP is the manufacturer's local regulatory contact for Swissmedic and carries defined obligations under the MedDO and IvDO that cannot be delegated to an EU or UK Authorised Representative. The CH-REP:
The appointment must be documented in a written mandate agreement signed by both parties before the CH-REP's details are placed on labels or IFU. Non-Swiss manufacturers cannot place devices on the Swiss market without appointing a CH-REP.
Although the EUDAMED and swissdamed registration requirements are similar, Manufacturers should note that swissdamed does not accept data imported directly from EUDAMED. The two databases are separate and act independently. Therefore, registrations must be completed separately for each system, and local obligations must be met.
No. Only Switzerland-based Economic Operators can register for a CHRN in swissdamed. For manufacturers not based in Switzerland, the Swiss Authorized Representative (who must be based in Switzerland) will hold the CHRN and register the manufacturer as an Actor in swissdamed.
Yes, though this role is not formally designated by the manufacturer. The CH importer is the entity or individual who first places the device on the market. As such, the CH-REP and CH importer roles are often fulfilled by the same entity or individual when in support of a foreign manufacturer. The importer must be identified with the device, either on the labeling, packaging, or other documentation supplied with the device. The importer is obligated to verify the manufacturer has fulfilled their obligations under MedDO or IvDO, register as an Economic Operator in swissdamed, keep records to allow traceability, and participate in post-market surveillance, including withdrawing devices if required and reporting serious incidents.
Our local partner’s expertise in Switzerland's medical device market offers you:
Guidance on device classification and determination of the appropriate regulatory pathway under the MDO.
Acting as your Swiss Authorized Representative includes swissdamed registration and more for a flat annual fee.

Pure Global offers flat-fee annual pricing for bundled Swiss Authorized Representative services and regulatory support, starting at $2,000/year. The flat fee includes document review, swissdamed registration, and Certificate of Free Sale (CFS) processing. Third party fees, when applicable, are not included.
Flat fee structure for medical devices and IVDs:
1 device or device group = $2,000/year
2-5 devices/groups = additional $500 per device per year (e.g., 5 devices = $4,000/year)
6-10 devices/groups = no additional cost (e.g., 8 devices - $4,000/year)
Contact us for a custom quote if you have 11+ devices.
A three-year contract is required to lock in the fees quoted above. However, other contractual arrangements are available. Use our Fee Calculator for an instant estimate and more information about flat fee terms.
Foreign manufacturers must: Appoint a Swiss Authorized Representative (Swiss AR or CH REP) to act on their behalf. Ensure pre-market registration and compliance with Swiss medical device regulations under the Medical Devices Ordinance (MDO), facilitated by the Swiss AR. Ensure the Swiss AR reports vigilance to Swissmedic on behalf of the manufacturer.
The Swiss AR ensures compliance with Swiss regulations, facilitates communication, handles pre-market registration, and reports vigilance to Swissmedic, enabling the manufacturer to sell their medical devices in Switzerland.
When you partner with Pure Global, a single registration process opens doors to multiple countries. Our global subsidiaries make this streamlined path possible.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Contact us